STOCK TITAN

VIVOS Inc (RDGL) president purchases 92,000 shares at $0.05

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VIVOS INC President Brad Allan Weeks reported open-market purchases of company common stock. He bought 60,000 shares on July 21, 2026 and 32,000 shares on July 22, 2026, each at $0.05 per share, for a total of 92,000 shares acquired directly.

Positive

  • None.

Negative

  • None.
Insider Weeks Brad Allan
Role President
Bought 92,000 shs ($5K)
Type Security Shares Price Value
Purchase Common Stock 32,000 $0.05 $2K
Purchase Common Stock 60,000 $0.05 $3K
Holdings After Transaction: Common Stock — 1,471,654 shares (Direct)
Shares purchased 2026-07-21 60000.0000 shares at $0.0500 per share Non-derivative Common Stock purchase by president Brad Allan Weeks on July 21, 2026
Shares purchased 2026-07-22 32000.0000 shares at $0.0500 per share Non-derivative Common Stock purchase by president Brad Allan Weeks on July 22, 2026
Total shares bought in reported period 92000 shares Aggregate insider purchases by Brad Allan Weeks across two transactions
Common Stock financial
"security_title Common Stock for each reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
non-derivative financial
"transaction_type non-derivative indicating direct share purchases"
acquired_disposed_code regulatory
"acquired_disposed_code A indicating acquisition of shares"
open market or private transaction financial
"transaction_code_description Purchase in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider share purchases were reported for RDGL's president?

VIVOS Inc president Brad Allan Weeks reported buying 92,000 common shares of RDGL in total. He purchased 60,000 shares on July 21, 2026 and 32,000 shares on July 22, 2026, all at a price of $0.05 per share.

At what price did the RDGL insider transactions occur?

Both reported insider purchases in RDGL were executed at $0.05 per share. Brad Allan Weeks acquired 60,000 shares on July 21, 2026 and 32,000 shares on July 22, 2026, with each non-derivative transaction priced consistently at $0.05.

How many separate insider transactions did RDGL disclose for its president?

Two separate insider purchase transactions were reported for RDGL’s president. Brad Allan Weeks bought 60,000 shares on July 21, 2026 and 32,000 shares on July 22, 2026, all as non-derivative Common Stock acquired directly in open-market or private transactions.

What type of security did RDGL’s president acquire in these insider trades?

Brad Allan Weeks acquired Common Stock of RDGL in both transactions. The Form 4 data classifies each as a non-derivative purchase of common shares, with direct ownership recorded and no associated derivative instruments reported in this set of transactions.

Were RDGL president Brad Allan Weeks’ insider trades under a Rule 10b5-1 plan?

The data shows the Rule 10b5-1 plan checkbox as not affirmed for these RDGL transactions. That means the 92,000 shares of Common Stock purchased by Brad Allan Weeks at $0.05 per share are not indicated as executed under a pre-arranged trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weeks Brad Allan

(Last)(First)(Middle)
C/O VIVOS INC.
1030 N CENTER PARKWAY

(Street)
KENNEWICK WASHINGTON 99336

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VIVOS INC [ RDGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/21/2026P60,000A$0.051,439,654D
Common Stock07/22/2026P32,000A$0.051,471,654D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Brad Weeks07/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)